X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (929) 929
Newsletter (23) 23
Book / eBook (9) 9
Magazine Article (9) 9
Book Chapter (2) 2
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (819) 819
humans (733) 733
impotence (714) 714
erectile dysfunction (529) 529
urology & nephrology (486) 486
index medicus (415) 415
middle aged (415) 415
adult (310) 310
aged (263) 263
impotence, vasculogenic - drug therapy (248) 248
erectile dysfunction - drug therapy (246) 246
men (220) 220
risk factors (206) 206
erectile dysfunction - etiology (190) 190
sildenafil citrate (184) 184
sildenafil (172) 172
penis - blood supply (170) 170
care and treatment (154) 154
penile erection - drug effects (151) 151
treatment outcome (146) 146
animals (144) 144
erectile dysfunction - physiopathology (134) 134
penile erection (132) 132
impotence, vasculogenic - etiology (119) 119
phosphodiesterase inhibitors - therapeutic use (119) 119
piperazines - therapeutic use (118) 118
erectile dysfunction - therapy (107) 107
impotence, vasculogenic - physiopathology (102) 102
drug therapy (101) 101
analysis (99) 99
prevalence (97) 97
erectile dysfunction - diagnosis (94) 94
therapy (92) 92
health aspects (89) 89
sexual disorders (89) 89
diabetes (88) 88
corpus cavernosum (86) 86
research (86) 86
rats (85) 85
purines (84) 84
sulfones (84) 84
vasodilator agents - administration & dosage (84) 84
nitric oxide (83) 83
sexual dysfunction (82) 82
penile erection - physiology (79) 79
diagnosis (78) 78
penis (76) 76
nitric-oxide (75) 75
vasodilator agents - therapeutic use (75) 75
risk-factors (74) 74
tadalafil (74) 74
alprostadil - administration & dosage (70) 70
surveys and questionnaires (69) 69
testosterone (68) 68
andrology (67) 67
double-blind (67) 67
endothelium (67) 67
penis - drug effects (67) 67
hypertension (66) 66
nitric-oxide synthase (66) 66
smooth-muscle (66) 66
injections (64) 64
medicine, general & internal (64) 64
dysfunction (63) 63
prospective studies (63) 63
urology (63) 63
endothelial dysfunction (62) 62
erectile dysfunction - epidemiology (62) 62
impotence, vasculogenic - diagnosis (62) 62
dose-response relationship, drug (60) 60
medicine & public health (60) 60
penis - diagnostic imaging (59) 59
phosphodiesterase 5 inhibitors - therapeutic use (59) 59
coronary-artery-disease (56) 56
efficacy (56) 56
papaverine (54) 54
international index (52) 52
sulfones - therapeutic use (52) 52
double-blind method (51) 51
papaverine - administration & dosage (51) 51
quality-of-life (51) 51
drug therapy, combination (49) 49
impotence, vasculogenic - therapy (48) 48
surgery (48) 48
aged, 80 and over (47) 47
alprostadil - therapeutic use (46) 46
penis - physiopathology (46) 46
cardiovascular disease (44) 44
impotence, vasculogenic - diagnostic imaging (44) 44
vasculogenic impotence (44) 44
atherosclerosis (43) 43
purines - therapeutic use (43) 43
comorbidity (42) 42
disease (42) 42
erectile dysfunction - psychology (42) 42
metabolic syndrome (42) 42
patient satisfaction (42) 42
piperazines - administration & dosage (42) 42
piperazines - adverse effects (42) 42
retrospective studies (42) 42
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (915) 915
German (27) 27
French (9) 9
Russian (9) 9
Japanese (5) 5
Italian (4) 4
Hungarian (3) 3
Chinese (2) 2
Dutch (2) 2
Spanish (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 10/2013, Volume 10, Issue 10, pp. 2430 - 2442
...Introduction Hypercholesterolemia is one of the most important risk factors in the development of vasculogenic erectile dysfunction (ED) [1,2] . This condition... 
Erectile Dysfunction | Hypercholesterolemia | Oxidative Stress | Angiotensin‐(1‐7) | Mas Receptor | Fibrosis | Hydroxypropyl‐Cyclodextrin | Hydroxypropyl-Cyclodextrin | Angiotensin-(1-7) | SYSTEM | ACTIVATION | PHYSIOLOGY | PENILE ERECTION | ENDOTHELIUM-DEPENDENT RELAXATION | MODEL | SMOOTH-MUSCLE | UROLOGY & NEPHROLOGY | CARDIAC FIBROSIS | AXIS | Impotence, Vasculogenic - drug therapy | Impotence, Vasculogenic - etiology | Reactive Oxygen Species - metabolism | Apolipoproteins E - deficiency | Receptors, G-Protein-Coupled - metabolism | Endothelium, Vascular - drug effects | Male | Phosphoproteins - metabolism | Penis - drug effects | Penile Erection - drug effects | Nitric Oxide Synthase Type III - metabolism | Penis - blood supply | Disease Models, Animal | Proto-Oncogene Proteins - metabolism | Nitric Oxide - blood | Administration, Oral | Mice, Inbred C57BL | Peptide Fragments - administration & dosage | Angiotensin I - administration & dosage | Endothelium, Vascular - physiopathology | Penis - physiopathology | Impotence, Vasculogenic - physiopathology | Mice, Knockout | Collagen - metabolism | Animals | Penis - metabolism | Endothelium, Vascular - metabolism | Apolipoproteins E - genetics | Cyclodextrins - administration & dosage | Nitric Oxide Synthase Type I - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Impotence, Vasculogenic - metabolism | Hypercholesterolemia - complications | Hypercholesterolemia - physiopathology | Mice | Hypercholesterolemia - genetics | Oxidative Stress - drug effects | Vasodilation - drug effects | Hypercholesterolemia - metabolism | Vasodilator Agents - administration & dosage | Phosphates | Niacinamide | Impotence | Collagen | Nitric oxide | Angiotensin | Cyclodextrins
Journal Article